# Sm-p80 Schistosomiasis Challenge Study

> **NCT05999825** · PHASE2 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 48 (estimated)

## Conditions studied

- Schistosoma Mansoni
- Schistosomiasis

## Interventions

- **BIOLOGICAL:** Sm-p80 + GLA-SE Vaccine
- **OTHER:** Placebo
- **BIOLOGICAL:** Schistosoma mansoni infection

## Key facts

- **NCT ID:** NCT05999825
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-09
- **Primary completion:** 2025-04
- **Final completion:** 2025-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05999825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05999825, "Sm-p80 Schistosomiasis Challenge Study". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05999825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*